FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126994175> ?p ?o ?g. }

• W3126994175 endingPage "137" @default.
• W3126994175 startingPage "133" @default.
• W3126994175 abstract "Objective Patients with coronavirus disease 2019 (COVID‐19) can progress to a state of unregulated inflammation called cytokine storm syndrome (CSS). We describe formation and operation of a COVID‐19 multidisciplinary consultation service that was allowed to individualize treatment for critically ill patients with COVID‐19 during the pandemic. Methods Institutional experts from different subspecialties formed a COVID‐19 CSS task force at Montefiore Medical Center, Bronx, NY. They agreed on a set of four clinical and six laboratory parameters that can help early identify COVID‐19 CSS. We describe the formation and implementation of the COVID‐19 task force. The case series description of the COVID‐19 CSS consultation cohort highlights consultation volume, baseline characteristics, clinical and laboratory parameters, and how biologic treatments were allocated to these patients. Results Between April 4,2020, and May 7,2020, the COVID‐19 CSS task force was formed, consisting of adult and pediatric rheumatologists and allergy and immunology physicians. The task force evaluated a total of 288 patients, of whom 197 (68%) were male, the median (interquartile range [IQR]) age was 62 (51‐70) years, 122 (42%) were Hispanic, and 88 (31%) were Black or African American. The common presenting symptoms in all referred patients were dyspnea (85%) and diarrhea (80%). Thirty‐one patients who received biologic therapy were younger, with a median (IQR) age of 53 (32‐63) years, as opposed to 62.5 (52‐70) years in the nonbiologic group ( P = 0.008). A higher proportion receiving biologics was in the critical care setting (26 [84%] vs 151 [59%]; P = 0.006). Conclusion To the best of our knowledge, this is the first multidisciplinary collaborative effort to provide individualized patient recommendations for evaluation and treatment of patients with COVID‐19 who may have CSS. This working model helped to devise an approach that may have identified patients who were most likely to benefit from biologic therapy in the absence of evidence‐based guidelines." @default.
• W3126994175 created "2021-02-15" @default.
• W3126994175 creator A5003579007 @default.
• W3126994175 creator A5006013534 @default.
• W3126994175 creator A5008978859 @default.
• W3126994175 creator A5016504404 @default.
• W3126994175 creator A5024061638 @default.
• W3126994175 creator A5028609593 @default.
• W3126994175 creator A5033484405 @default.
• W3126994175 creator A5051049867 @default.
• W3126994175 creator A5053860765 @default.
• W3126994175 creator A5057366487 @default.
• W3126994175 creator A5068037550 @default.
• W3126994175 creator A5083131319 @default.
• W3126994175 creator A5086383120 @default.
• W3126994175 creator A5087333389 @default.
• W3126994175 creator A5088160820 @default.
• W3126994175 creator A5091278998 @default.
• W3126994175 date "2021-02-06" @default.
• W3126994175 modified "2023-09-27" @default.
• W3126994175 title "Rapid Implementation of a Multidisciplinary COVID‐19 Cytokine Storm Syndrome Task Force" @default.
• W3126994175 cites W2142328532 @default.
• W3126994175 cites W2267315119 @default.
• W3126994175 cites W2582439522 @default.
• W3126994175 cites W3009885589 @default.
• W3126994175 cites W3012421327 @default.
• W3126994175 cites W3012696170 @default.
• W3126994175 cites W3014050022 @default.
• W3126994175 doi "https://doi.org/10.1002/acr2.11220" @default.
• W3126994175 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7966876" @default.
• W3126994175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33547873" @default.
• W3126994175 hasPublicationYear "2021" @default.
• W3126994175 type Work @default.
• W3126994175 sameAs 3126994175 @default.
• W3126994175 citedByCount "2" @default.
• W3126994175 countsByYear W31269941752021 @default.
• W3126994175 countsByYear W31269941752022 @default.
• W3126994175 crossrefType "journal-article" @default.
• W3126994175 hasAuthorship W3126994175A5003579007 @default.
• W3126994175 hasAuthorship W3126994175A5006013534 @default.
• W3126994175 hasAuthorship W3126994175A5008978859 @default.
• W3126994175 hasAuthorship W3126994175A5016504404 @default.
• W3126994175 hasAuthorship W3126994175A5024061638 @default.
• W3126994175 hasAuthorship W3126994175A5028609593 @default.
• W3126994175 hasAuthorship W3126994175A5033484405 @default.
• W3126994175 hasAuthorship W3126994175A5051049867 @default.
• W3126994175 hasAuthorship W3126994175A5053860765 @default.
• W3126994175 hasAuthorship W3126994175A5057366487 @default.
• W3126994175 hasAuthorship W3126994175A5068037550 @default.
• W3126994175 hasAuthorship W3126994175A5083131319 @default.
• W3126994175 hasAuthorship W3126994175A5086383120 @default.
• W3126994175 hasAuthorship W3126994175A5087333389 @default.
• W3126994175 hasAuthorship W3126994175A5088160820 @default.
• W3126994175 hasAuthorship W3126994175A5091278998 @default.
• W3126994175 hasBestOaLocation W31269941751 @default.
• W3126994175 hasConcept C119060515 @default.
• W3126994175 hasConcept C126322002 @default.
• W3126994175 hasConcept C17744445 @default.
• W3126994175 hasConcept C1862650 @default.
• W3126994175 hasConcept C187212893 @default.
• W3126994175 hasConcept C2779134260 @default.
• W3126994175 hasConcept C2779559532 @default.
• W3126994175 hasConcept C2780850621 @default.
• W3126994175 hasConcept C2985871740 @default.
• W3126994175 hasConcept C3008058167 @default.
• W3126994175 hasConcept C3116431 @default.
• W3126994175 hasConcept C524204448 @default.
• W3126994175 hasConcept C71924100 @default.
• W3126994175 hasConcept C72563966 @default.
• W3126994175 hasConceptScore W3126994175C119060515 @default.
• W3126994175 hasConceptScore W3126994175C126322002 @default.
• W3126994175 hasConceptScore W3126994175C17744445 @default.
• W3126994175 hasConceptScore W3126994175C1862650 @default.
• W3126994175 hasConceptScore W3126994175C187212893 @default.
• W3126994175 hasConceptScore W3126994175C2779134260 @default.
• W3126994175 hasConceptScore W3126994175C2779559532 @default.
• W3126994175 hasConceptScore W3126994175C2780850621 @default.
• W3126994175 hasConceptScore W3126994175C2985871740 @default.
• W3126994175 hasConceptScore W3126994175C3008058167 @default.
• W3126994175 hasConceptScore W3126994175C3116431 @default.
• W3126994175 hasConceptScore W3126994175C524204448 @default.
• W3126994175 hasConceptScore W3126994175C71924100 @default.
• W3126994175 hasConceptScore W3126994175C72563966 @default.
• W3126994175 hasIssue "3" @default.
• W3126994175 hasLocation W31269941751 @default.
• W3126994175 hasLocation W31269941752 @default.
• W3126994175 hasOpenAccess W3126994175 @default.
• W3126994175 hasPrimaryLocation W31269941751 @default.
• W3126994175 hasRelatedWork W2061253854 @default.
• W3126994175 hasRelatedWork W2315085516 @default.
• W3126994175 hasRelatedWork W2603773853 @default.
• W3126994175 hasRelatedWork W2971392718 @default.
• W3126994175 hasRelatedWork W3032047981 @default.
• W3126994175 hasRelatedWork W3037686638 @default.
• W3126994175 hasRelatedWork W3047680733 @default.
• W3126994175 hasRelatedWork W3128731474 @default.
• W3126994175 hasRelatedWork W3162511055 @default.
• W3126994175 hasRelatedWork W4313139988 @default.

• next